fantasy stock market

Nike, Inc. (NYSE:NKE) is just doing it when it comes to taking control of its ecommerce sales. They recently announced they will begin selling merchandise on Amazon.com (NASDAQ:AMZN). Although you or I have been able to buy Nike merchandise on Amazon before, it has only been through third-party resellers. Thats why people have been buying $190 shoes for $300.

Nike is an American multinational corporation that designs, develops, manufactures, and sells footwear, apparel, equipment, and accessories. They are one of the worlds largest suppliers of sportswear. Nike was founded by Bill Bowerman and Phil Knight in 1964. It was originally called Blue Ribbon Sports, but officially became Nike, Inc. in 1971. After a few short years, in 1980, Nike had obtained fifty percent of the market share in the U.S. for athletic shoes, and they havent looked back since.

fantasy stock market: Fluor Corporation(FLR)

Advisors’ Opinion:

  • [By David Zeiler]

    Construction stocks Fluor (NYSE: FLR) and Granite Construction Inc. (NYSE: GVA) both rose about 8%; Vulcan Materials Co. (NYSE: VMC) jumped nearly 10%.

  • [By Paul Ausick]

    Fluor Corp. (NYSE: FLR) dropped about 6.3% Monday to post a new 52-week low of $41.78 after closing at $44.58 on Friday. The stock’s 52-week high is $58.37. Volume of about 3.5 million was more than double the daily average. The company had no specific news.

fantasy stock market: Unilever NV(UN)

Advisors’ Opinion:

  • [By Teresa Rivas]

    Earlier this year, Unilever (UN) recently declined Kraft Heinz (KHC) merger bid. That means that if the company still wants to do a deal, Mondelez International (MDLZ) and PepsiCo (PEP) are the next logical partners, writes Susquehannas Pablo Zuanic.

    Getty Images

    Zuanic upgraded Pepsi from Neutral to Positive today and raised his price target from $118 to $132. He writes that a Pepsi deal would have more strategic merits, hence his upgrade (as he emphasizes that not much has changed in terms of fundamentals for the firm).

    More detail from his note:

    With investors apparently seeing MDLZ as the next likely KHC target, and Coca-Cola (KO) the next Anheuser-Busch (BUD) target, PEP shares have lost visibility and now trade at a 25% discount to KO on apples-to-apples comps. We see value here, on franchise strength, efforts to align the F&B portfolio with consumer health trends, and the growing optionality value of a joint KHC/BUD bid for PEP. We argue that, together, the Kendall Jenner commercial, the Aspartame to-be-or-not-to-be zigzagging, the new, new, new alt low-cal cola (Pepsi Zero sugar), the ongoing underperformance in U.S. CSDs (25% only of the company), the lack of scale in non-CSD NARTDs vs. KO (other than Gatorade), and now talk of PEP buying Brazilian dairy company Vigor S.A. (a JBS subsidiary that would better fit KHC or ULVR), all paint a picture of a company still struggling to set a new direction (with all due respect). In this regard, we think PEP may be more vulnerable than MDLZ to a KHC bid (jointly done with BUD). We also see greater strategic fit for KHC with PEP Food/Snacks (than with MDLZ), and argue that PEP Beverages fits BUD better than KO, as the PEP bottling operations in key regions (including NA) remain in the hands of PEP (KO, on the other hand will be fully refranchised by end of 2017). So we are upgrading PEP to Positive with a $132 price target by December 17. Yes, the Unilever rebuff

  • [By Lisa Levin]

    In trading on Tuesday, industrial shares fell by 0.04 percent. Meanwhile, top losers in the sector included Unilever N.V. (ADR) (NYSE: UN), down 8 percent, and Magal Security Systems Ltd. (USA) (NASDAQ: MAGS), down 6 percent.

fantasy stock market: DBV Technologies S.A.(DBVT)

Advisors’ Opinion:

  • [By Lisa Levin]

    DBV Technologies SA – ADR (NASDAQ: DBVT) shares dropped 46 percent to $26.11 after the company disclosed that its peanut allergy trial failed to meet primary endpoint.

  • [By Lisa Levin]

     

    Losers
    DBV Technologies SA – ADR (NASDAQ: DBVT) shares tumbled 50.6 percent to $23.73 after the company disclosed that its peanut allergy trial failed to meet primary endpoint.
    Connecture Inc (NASDAQ: CNXR) shares declined 40.8 percent to $0.290. Connecture reported that it will voluntarily delist from the NASDAQ for OTCQX Market.
    Walter Investment Management Corp (NYSE: WAC) slipped 19.2 percent to $0.410. On Friday, Walter Investment Management disclosed that it has reached an agreement with term lenders and senior noteholders on financial restructuring.
    Eldorado Gold Corp (USA) (NYSE: EGO) shares dropped 15.9 percent to $1.83. Eldorado Gold lowered its production guidance for its Kisladag operation.
    Seanergy Maritime Holdings Corp. (NASDAQ: SHIP) shares fell 15.4 percent to $1.04.
    Future Fintech Group Inc (NASDAQ: FTFT) dropped 13.6 percent to $1.53. Future FinTech reported filing of proxy statement, including proposal for corporate restructuring.
    Concordia International Corp (NASDAQ: CXRX) shares fell 12.3 percent to $0.500 after dipping 38.71 percent on Friday.
    Aemetis Inc (NASDAQ: AMTX) shares declined 11.3 percent to $0.550
    OncoSec Medical Inc (NASDAQ: ONCS) dipped 10.5 percent to $1.12. OncoSec reported a $7.1 million registered direct at-the-market offering at a price of $1.34375 per share.
    Evoke Pharma Inc (NASDAQ: EVOK) shares fell 10.35 percent to $3.08 after the company disclosed 'positive' topline results from comparative exposure pharmacokinetic study for Gimoti.
    Eiger Biopharmaceuticals Inc (NASDAQ: EIGR) shares dropped 9.4 percent to $11.60 as the company disclosed Phase 2 interim 24-week data with pegylated interferon lambda in Hepatitis Delta Virus infection at the American Association for the Study of Liver Diseases Meeting.
    Viking Therapeutics Inc (NASDAQ: VKTX) shares slipped 6.6 percent to $2.80. Viking Therapeutics presented results from proof-of-concept study of VK0214 in in vivo

  • [By Monica Gerson]

    DBV Technologies SA ADR (NASDAQ: DBVT) is expected to post a quarterly loss at $0.60 per share.

    Northern Technologies International Corp (NASDAQ: NTIC) is projected to post its quarterly earnings.

fantasy stock market: Fastenal Company(FAST)

Advisors’ Opinion:

  • [By Monica Gerson]

    Fastenal Company (NASDAQ: FAST) is estimated to report its quarterly earnings at $0.45 per share on revenue of $988.60 million.

    Perry Ellis International, Inc. (NASDAQ: PERY) is projected to report its quarterly earnings at $0.35 per share on revenue of $214.26 million.

  • [By Monica Gerson]

    Breaking news

    Shares of Alcoa Inc (NYSE: AA) dropped over 7 percent in pre-market trading after the company reported Q3 results. Alcoa posted Q3 adjusted earnings of $0.32 per share on sales of $5.2 billion.
    Fastenal Company (NASDAQ: FAST) released third quarter financial results, reporting an earnings miss while revenue came in line with Street estimates. To read the full news, click here.
    Twilio Inc (NYSE: TWLO) announced preliminary results for the third quarter that came in above the Street estimates. To read the full news, click here.
    According to the Associated Press, Samsung Electronics (OTC: SSNLF) said it will no longer manufacturer its Galaxy Note 7 smartphones. The permanent discontinuation follows a round of reports saying customer's replacement phones have caught fire. To read the full news, click here.

fantasy stock market: Patterson Companies, Inc.(PDCO)

Advisors’ Opinion:

  • [By Keith Speights]

    The three top dividend stocks in the dentistry industry are Patterson Companies (NASDAQ:PDCO), Zimmer Biomet Holdings (NYSE:ZBH), and Danaher (NYSE:DHR). But two of these, Zimmer Biomet and Danaher, pay out only small dividends.

  • [By Chuck Saletta]

    Patterson Companies (NASDAQ:PDCO) has been around since 1877; it’s a strong player in human dental health services and a big distributor of animal-health-related products. With around 140 years of history behind it, Patterson knows how to survive times of war and economic turmoil, which should give you reason to believe it will be around for some time to come.

  • [By Paul Ausick]

    Patterson Companies Inc. (NASDAQ: PDCO) dropped about 7.9% Tuesday to post a new 52-week low of $32.07 after closing at $34.82 on Monday. The 52-week high is $48.30. Volume was around 5 million, more than three times the daily average of around 1.6 million. The distributor of dental and animal health care products missed earnings and revenues estimates this morning.

fantasy stock market: Benitec Biopharma Limited(BNTC)

Advisors’ Opinion:

  • [By Lisa Levin]

    Benitec Biopharma Ltd (ADR) (NASDAQ: BNTC) shares shot up 44 percent to $4.41. Benitec Biopharma disclosed that the key pre-clinical data on oculopharyngeal muscular dystrophy has been published in Nature Communications.

  • [By Alex McGuire]

    Here’s a list of the top 10 penny stocks to watch in March, which includes the biggest gainers last month…

    Penny StockCurrent Stock PriceFebruary 2017 ReturnZosano Pharma Corp. (Nasdaq: ZSAN)$2.56+123.3%Bellerophon Therapeutics Inc. (Nasdaq: BLPH)$1.25+113.8%Peregrine Pharmaceuticals (Nasdaq: PPHM)$0.59+101.7%Galectin Therapeutics Inc. (Nasdaq: GALT)$1.79+91.9%Bioanalytical Systems Inc. (Nasdaq: BASI)$1.58+90.6%CymaBay Therapeutics Inc. (Nasdaq: CBAY)$3.50+89.8%Vermillion Inc. (Nasdaq: VRML)$2.56+86.3%Naked Brand Group Inc.(Nasdaq:NAKD)$2.16+76%Eyegate Pharmaceuticals Inc. (Nasdaq: EYEG)$2.63+73.9%Benitec Biopharma Ltd. (Nasdaq ADR: BNTC)$2.60+59.9%

    The best-performing penny stock – Zosano Pharma Corp. – soared an incredible 123.3% from Feb. 1 to Feb. 28. To put those gains into perspective, that’s more than five times the S&P 500’s 23% climb in the last 12 months.

Leave a Reply

Your email address will not be published. Required fields are marked *